Related Experiment Video
Updated: Aug 7, 2025

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
Immunotherapy in endometrial cancer
Haider Mahdi1, Anca Chelariu-Raicu2, Brian M Slomovitz3
1Division of Gynecologic Oncology, UPMC Magee Womens Hospital, Pittsburgh, Pennsylvania, USA.
Immune checkpoint inhibitors show promise in endometrial cancer, with distinct efficacy based on molecular subtypes. Combination therapies may improve outcomes in microsatellite stable disease and overcome resistance in microsatellite unstable disease.
Area of Science:
- Oncology
- Immunotherapy
- Genomics
Background:
- The Cancer Genome Atlas (TCGA) provides insights into endometrial cancer molecular subtypes.
- Immune checkpoint inhibitors (ICIs) are a key focus in cancer treatment.
Purpose of the Study:
- To review current immunotherapy indications for advanced/recurrent endometrial cancer.
- To explore future combination strategies for enhancing ICI response and overcoming resistance.
Main Methods:
- Review of TCGA endometrial cancer data.
- Analysis of ICI efficacy in different molecular subtypes (microsatellite unstable vs. stable).
Main Results:
- ICIs show single-agent activity in microsatellite instability-high (MSI-H) endometrial cancer.
- Combination approaches significantly improve efficacy in microsatellite stable (MSS) endometrial cancer.
- Strategies to enhance response or reverse resistance in MSI-H endometrial cancer are needed.
Conclusions:
- Immunotherapy offers distinct treatment avenues for endometrial cancer based on molecular profile.
- Combination strategies are crucial for improving outcomes in both MSI-H and MSS endometrial cancer.
- Further research is required to optimize safety, tolerability, and efficacy of immunotherapy combinations.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...